Observed Signal · May 28, 2026 · Funding · Source: techcrunch · Impact: 2/5 · Sentiment: Positive

H1 raises $40M led by CVS Health Ventures

Executive Signal Summary

H1, a nine-year-old healthcare data platform, raised $40 million in a round led by CVS Health Ventures. CEO and co-founder Ariel Katz said H1 — which licenses detailed physician data to pharma companies, hospital systems and insurers — turned cash-flow and EBITDA profitable last year and is forecasting over 40% growth this year. Katz argued that being a data-first provider makes H1 less vulnerable to AI replacement and could make it a supplier to model makers. H1 was last valued at $750 million after a $100 million round in November 2021 led by Altimeter Capital, and the company has grown through acquisitions of smaller competitors and complementary businesses.

Polaris7 AgentPolaris7 Strategic Assessment
High Confidence

Corporate VC backing of a profitable, data-first B2B SaaS provider signals investor interest in sustainable data businesses but is not industry-shifting.

SIGNAL RADAR

Track Anthropic Signals & Market Shifts in Real-Time

Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.

Start Free in Explorer
Free Explorer tierNo credit card requiredInstant watchlist setup

Key Takeaways & Evidence Grounding

  • CVS Health Ventures led a $40 million investment into H1.
  • H1 is a nine-year-old healthcare data platform that sells detailed physician information to pharma, hospital systems, and health insurers.
  • H1 turned cash-flow and EBITDA profitable in the prior year and is forecasting over 40% growth for the current year.
  • H1 was last valued at $750 million after raising $100 million in November 2021 led by Altimeter Capital.
  • H1 has expanded through acquisitions of smaller competitors and complementary businesses.
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: techcrunch•Published: May 28, 2026
Original Coverage Title: “H1 secures $40M from CVS, proving SaaS startups can still attract investment”

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

AI in HealthcareSep 22, 2026

Health AI Startup Heidi Raises $340M at $900M Valuation

Australian health AI startup Heidi has closed a Series C round of $100 million, led by Blackbird, with participation from Phoenix Court, Point72 Private Investments, and Headline, valuing the company at $900 million. In parallel, Heidi secured $240 million in growth financing from General Catalyst's Customer Value Fund, a revenue-based instrument that covers sales and customer acquisition costs. Combined, these deals provide $340 million in fresh capital. The company has raised $436.6 million to date. Heidi, founded in Melbourne, started as an AI scribe for clinical documentation and now positions itself as an 'AI care partner'. It reports 2.8 million patient encounters per week across 190 countries. The funding will support regulatory work for advanced clinical features in Europe and the UK, and expansion in the DACH region.

Read assessment
FundingSep 18, 2026

Angle Health raises $600M at $2.7B valuation

Health insurance startup Angle Health announced a $200 million Series C round and a $400 million tender offer, giving the company a $2.7 billion valuation. The round was led by Vitruvian Partners with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. The tender offer permits employees to cash out shares, and the transaction is expected to close later this month. Angle Health, a Winter 2020 Y Combinator alum, helps small businesses manage level-funded health plans, offering a middle ground between fully insured and self-funded options. The company's AI-powered platform integrates with payroll and HR systems, serves over 5,000 businesses, and is reportedly profitable. This funding round is notable as it comes from a non-AI-agent startup founded in 2019.

Read assessment
FundingJun 22, 2026

Hightouch Reaches $2.75B Valuation After $150M Series D

Hightouch, a marketing data and AI startup founded out of Y Combinator in 2018, closed a $150 million Series D led by Goldman Sachs Alternatives and Bain Capital Ventures in April 2026, with participation from TD7 (The Trade Desk’s investment arm). The round brings the company’s total raised across six rounds to about $322 million and values Hightouch at $2.75 billion. The firm reports roughly $100 million in ARR, a headcount above 400, and blue‑chip customers including Domino’s Pizza, DoorDash, PetSmart, Aritzia, Spotify and the NBA. Hightouch pivoted from a reverse‑ETL/data‑sync product toward AI‑led content and campaign generation, and plans to use the new capital primarily for engineering and customer‑facing hires. The company also made an unsolicited approach to Publicis to buy LiveRamp’s identity business for up to $1.2 billion.

Read assessment

Track Real-Time Market Signals & Shifts

Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.